News + Filings Transactions
|
Hopfner Robert Lorne
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 08/01/2023 | Inozyme Pharma, Inc. | INZY | Purchase | Common Stock | 119k | $4.80 | $571.4k | By Pivotal | 08/01/2023 |
| 08/01/2023 | Inozyme Pharma, Inc. | INZY | Purchase | Common Stock | 714.3k | $4.80 | $3.4M | By Pivotal | 08/01/2023 |
| 05/17/2023 | Rallybio Corp | RLYB | Grant | Option (Right to Buy) | 15.5k | $5.64 | $87.4k | | 05/17/2023 |
| 05/12/2023 | Inozyme Pharma, Inc. | INZY | Purchase | Common Stock | 228.7k | $6.25 | $1.4M | By Pivotal | 05/11/2023 |
| 05/11/2023 | Inozyme Pharma, Inc. | INZY | Purchase | Common Stock | 219.2k | $6.48 | $1.4M | By Pivotal | 05/11/2023 |
| 06/10/2022 | Inozyme Pharma, Inc. | INZY | Grant | Stock Option (Right to Buy) | 9.4k | $4.38 | $41k | | 06/10/2022 |
| 05/24/2022 | Rallybio Corp | RLYB | Grant | Option (Right to Buy) | 13.4k | $12.75 | $171.4k | | 05/24/2022 |
| 04/19/2022 | Inozyme Pharma, Inc. | INZY | Purchase | Common Stock | 1.1M | $3.69 | $3.9M | By Pivotal bioVenture Partners Fund I, L.P. | 04/19/2022 |
| 01/03/2022 | Rallybio Corp | RLYB | Grant | Option (Right to Buy) | 6.2k | $10.38 | $64.8k | | 01/03/2022 |
| 08/02/2021 | Rallybio Corp | RLYB | Purchase | Common Stock | 576.9k | $13.00 | $7.5M | Pivotal bioVenture Partners Fund I L.P | 07/28/2021 |
| 07/28/2021 | Rallybio Corp | RLYB | Other (disposition) | Series B Preferred Units | 10.8M | $0.00 | $0 | Pivotal bioVenture Partners Fund I L.P. | 07/28/2021 |
| 07/28/2021 | Rallybio Corp | RLYB | Grant | Option (Right to Buy) | 13.4k | $13.00 | $174.7k | | 07/28/2021 |
| 07/28/2021 | Rallybio Corp | RLYB | Other (acquisition) | Common Stock | 1.7M | $0.00 | $0 | Pivotal bioVenture Partners Fund I L.P | 07/28/2021 |
| 06/23/2021 | Inozyme Pharma, Inc. | INZY | Grant | Stock Option (right to buy) | 9.4k | $17.12 | $160.4k | | 06/23/2021 |
| 06/02/2021 | Vaxcyte, Inc. | PCVX | Grant | Stock Option (right to buy) | 15k | $21.49 | $322.4k | | 06/02/2021 |
| 02/10/2021 | Vaxcyte, Inc. | PCVX | Sale | Common Stock | 37.3k | $25.75 | $959.7k | By Pivotal bioVenture Partners Fund I, L.P. | 02/08/2021 |
| 02/10/2021 | Vaxcyte, Inc. | PCVX | Sale | Common Stock | 26.7k | $26.78 | $714.7k | By Pivotal bioVenture Partners Fund I, L.P. | 02/08/2021 |
| 02/10/2021 | Vaxcyte, Inc. | PCVX | Sale | Common Stock | 7.6k | $27.64 | $209.2k | By Pivotal bioVenture Partners Fund I, L.P. | 02/08/2021 |
| 02/10/2021 | Vaxcyte, Inc. | PCVX | Sale | Common Stock | 6.6k | $28.66 | $190.1k | By Pivotal bioVenture Partners Fund I, L.P. | 02/08/2021 |
| 02/09/2021 | Vaxcyte, Inc. | PCVX | Sale | Common Stock | 38.2k | $27.12 | $1M | By Pivotal bioVenture Partners Fund I, L.P. | 02/08/2021 |
| 02/09/2021 | Vaxcyte, Inc. | PCVX | Sale | Common Stock | 88.8k | $28.07 | $2.5M | By Pivotal bioVenture Partners Fund I, L.P. | 02/08/2021 |
| 02/09/2021 | Vaxcyte, Inc. | PCVX | Sale | Common Stock | 93.7k | $28.75 | $2.7M | By Pivotal bioVenture Partners Fund I, L.P. | 02/08/2021 |
| 02/08/2021 | Vaxcyte, Inc. | PCVX | Sale | Common Stock | 50.9k | $25.64 | $1.3M | By Pivotal bioVenture Partners Fund I, L.P. | 02/08/2021 |
| 02/08/2021 | Vaxcyte, Inc. | PCVX | Sale | Common Stock | 28.9k | $26.06 | $753.7k | By Pivotal bioVenture Partners Fund I, L.P. | 02/08/2021 |
| 02/03/2021 | Vaxcyte, Inc. | PCVX | Sale | Common Stock | 2.8k | $25.06 | $69.4k | By Pivotal bioVenture Partners Fund I, L.P. | 02/02/2021 |
| 02/02/2021 | Vaxcyte, Inc. | PCVX | Sale | Common Stock | 14.2k | $25.13 | $357.7k | By Pivotal bioVenture Partners Fund I, L.P. | 02/02/2021 |
| 01/28/2021 | Vaxcyte, Inc. | PCVX | Sale | Common Stock | 2k | $25.07 | $50.1k | By Pivotal bioVenture Partners Fund I, L.P. | 01/28/2021 |
| 01/27/2021 | Vaxcyte, Inc. | PCVX | Sale | Common Stock | 2.1k | $25.30 | $54.1k | By Pivotal bioVenture Partners Fund I, L.P. | 01/25/2021 |
| 01/26/2021 | Vaxcyte, Inc. | PCVX | Sale | Common Stock | 1.4k | $26.13 | $35.9k | By Pivotal bioVenture Partners Fund I, L.P. | 01/25/2021 |
| 01/26/2021 | Vaxcyte, Inc. | PCVX | Sale | Common Stock | 16.8k | $25.23 | $423.1k | By Pivotal bioVenture Partners Fund I, L.P. | 01/25/2021 |
| 01/25/2021 | Vaxcyte, Inc. | PCVX | Sale | Common Stock | 15.5k | $26.07 | $403.1k | By Pivotal bioVenture Partners Fund I, L.P. | 01/25/2021 |
| 01/25/2021 | Vaxcyte, Inc. | PCVX | Sale | Common Stock | 19.5k | $25.61 | $499.7k | By Pivotal bioVenture Partners Fund I, L.P. | 01/25/2021 |
| 01/22/2021 | Vaxcyte, Inc. | PCVX | Sale | Common Stock | 11.4k | $25.16 | $286.4k | By Pivotal bioVenture Partners Fund I, L.P. | 01/20/2021 |
| 01/21/2021 | Vaxcyte, Inc. | PCVX | Sale | Common Stock | 100 | $25.11 | $2.5k | By Pivotal bioVenture Partners Fund I, L.P. | 01/20/2021 |
| 01/20/2021 | Vaxcyte, Inc. | PCVX | Sale | Common Stock | 19k | $25.35 | $482.8k | By Pivotal bioVenture Partners Fund I, L.P. | 01/20/2021 |
|
|